AC Immune SA
ACIU
$1.68
$0.021.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -17.67% | -382.73% | 125.28% | -23.20% | -281.31% |
| Total Depreciation and Amortization | 13.01% | -1.50% | 0.92% | -4.70% | 1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 260.03% | 2.02% | -113.25% | 3,974.73% | -91.57% |
| Change in Net Operating Assets | -110.03% | 215.84% | -123.10% | 359.38% | 225.45% |
| Cash from Operations | -409.75% | 141.32% | -120.25% | 6,795.22% | 106.41% |
| Capital Expenditure | -292.88% | 47.54% | -159.84% | 73.60% | -51.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 188.64% | -91.85% | 97.35% | -214.17% | -200.69% |
| Cash from Investing | 177.31% | -80.56% | 97.12% | -211.13% | -202.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -47.95% | 0.58% | 0.58% | -3.59% | -20.14% |
| Issuance of Common Stock | -- | -- | -- | 6,650.00% | -100.00% |
| Repurchase of Common Stock | -- | -2,400.00% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -400.00% | -- | 100.00% | 95.41% | -- |
| Cash from Financing | -27.95% | -12.15% | -191.55% | 91.28% | -101.70% |
| Foreign Exchange rate Adjustments | -113.50% | 169.88% | -10.59% | -244.14% | 213.69% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -513.10% | 119.85% | -267.64% | 75.50% | -146.73% |